GlassScriptPhysician profile
Scott W Shelfo
NPI 1053414458
$5,219.83
in general payments reported to CMS, 2019-2025
26 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $262 · 2021: $429 · 2022: $3,013 · 2023: $361 · 2024: $104 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,163.56 | 2021-2022 | |
| Boston Scientific Corporation | $404.24 | 2021-2025 | Ams 700, Advance Xp |
| Novartis Pharmaceuticals Corporation | $247.22 | 2019-2020 | |
| Astellas Pharma US INC | $215.03 | 2019-2020 | |
| Teleflex LLC | $148.86 | 2023-2024 | Urolift |
| Janssen Biotech, INC. | $120.56 | 2019-2025 | Erleada |
| Amgen INC. | $93.82 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $93.64 | 2019-2020 | |
| Angiodynamics, INC. | $92.72 | 2023-2024 | Nanoknife |
| Seagen INC. | $79.95 | 2019 | |
| Rochester Medical Corporation | $67.26 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.52 | 2019-2021 | |
| Ambu INC. | $51.02 | 2021 | |
| Immunitybio, INC. | $46.60 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $43.91 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $43.25 | 2019 | |
| Eisai INC. | $42.52 | 2019-2020 | |
| Ethicon US, LLC | $38.37 | 2021 | |
| Urogen Pharma, INC. | $33.49 | 2025 | |
| Axonics, INC. | $26.00 | 2023 | Bulkamid, Axonics |
| Ferring Pharmaceuticals INC. | $21.35 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $19.96 | 2019 | |
| Array Biopharma INC | $19.47 | 2019 | |
| Koelis INC. | $17.02 | 2019 | |
| Genzyme Corporation | $13.16 | 2019 | |
| Exelixis INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Shelfo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.